COVID-19 at-home test kits are in short supply; 2021 is on track to surpass 2020's death toll; hospitals report patient surges.
The unprecedented demand for at-home COVID-19 test kits ahead of the 2021 holiday season has led major pharmacy chains Walgreens and CVS to ration individual purchases, USA Today reports. At Walgreens, customers are limited to purchasing 4 home test kits, while at CVS, that limit is set at 6. Some stores may say they’re out of stock online while in-person stock is available in some communities. Yesterday, President Joe Biden announced his administration will mail 500 million at-home test kits for free in January.
According to the Associated Press, health officials say 2021 is on track to be even more deadly than 2020 in the United States. It will still be weeks before accurate death counts from November and December are processed, but publicly available information indicates this year’s death toll is likely to surpass that of 2020 by at least 15,000. Last year was the deadliest in the nation’s history, due in large part to the COVID-19 pandemic, and updated data show that figures are worse than what the CDC previously reported. Life expectancy in 2020 also fell by 1.8 years compared with 2019.
Hospitals around the country are struggling with the latest increase in COVID-19 cases fueled by the Omicron variant and the still-present Delta variant, NBC News reports. An ongoing shortage of personnel is also complicating matters, and The New York Times reports that 2 of the 3 monoclonal antibodies doctors have depended on to treat COVID-19 patients do not seem as effective against the Omicron variant. The remaining seemingly effective treatment is now in short supply. However, according to The Washington Post, new data indicate early use of convalescent plasma could help prevent infections with the Omicron variant from becoming severe.
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Contributor: For Complex Cases, Continuity in Acute Care Is Necessary
April 23rd 2025For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen